Drug profile · INN
autologous cartilage-derived articular chondrocytes, in-vitro expanded
JELRIX
- Patents linked
- 0
- News articles
- 0
Quick answer
autologous cartilage-derived articular chondrocytes, in-vitro expanded (JELRIX) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN autologous cartilage-derived articular chondrocytes, in-vitro expanded
Brand JELRIX
ATC code M09AX02
Frequently asked questions
What is autologous cartilage-derived articular chondrocytes, in-vitro expanded?
autologous cartilage-derived articular chondrocytes, in-vitro expanded (JELRIX) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for autologous cartilage-derived articular chondrocytes, in-vitro expanded?
JELRIX is a marketed brand name for autologous cartilage-derived articular chondrocytes, in-vitro expanded. Check FDA Drugs@FDA for the current US label holder and prescribing information.